Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 9,330 | 18,147 | 3,966 | 1,979 | 335 |
| Gross Profit | 9,330 | 18,147 | 3,966 | 1,979 | 335 |
| Operating Expenses | 88,443 | 81,363 | 46,772 | 43,709 | 33,556 |
| Operating Income | -79,113 | -63,216 | -42,806 | -41,730 | -33,221 |
| Other Income | 833 | 2,291 | 1,144 | 1,844 | 580 |
| Pre-tax Income | -78,280 | -60,925 | -41,662 | -39,886 | -32,641 |
| Net Income Continuous | -78,280 | -60,925 | -41,662 | -39,886 | -32,641 |
| Minority Interests | N/A | N/A | N/A | -1,143 | -7,150 |
| Net Income | $-78,280 | $-60,925 | $-41,662 | $-38,743 | $-25,491 |
| EPS Basic Total Ops | -3.52 | -3.35 | -2.60 | -17.82 | -95.87 |
| EPS Basic Continuous Ops | -3.50 | -3.35 | -2.60 | -15.42 | -104.56 |
| EPS Diluted Total Ops | -3.52 | -3.35 | -2.60 | -17.82 | -95.87 |
| EPS Diluted Continuous Ops | -3.50 | -3.35 | -2.60 | -15.42 | -104.56 |
| EPS Diluted Before Non-Recurring Items | -3.52 | -3.35 | N/A | N/A | N/A |
| EBITDA(a) | $-78,352 | $-62,466 | $-42,397 | $-41,367 | $-32,942 |